| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Jun―26 |
Squalene: A High-Value Compound for COVID-19 Vaccine Adjuvants and Beyond Pathways, Production Strategies, and Market Potential |
Dileep Dasari, Reeta Rani Singhania, Shashi Kant Bhatia, Cheng-Di Dong, Anil Kumar Patel |
| 2 |
[GO] |
2024―Jun―26 |
Potential COVID-19 remedies from repurposed drugs and herbal small RNAs |
Yang Yang, Fengming Huang, Xiangyu Qiao, Sheng Chen, Cong Zhang, Xingyu Deng, Wentao Gu, Ling Peng, Mengli Cao, Jingmei Jiang, George F. Gao, Yingxia Liu, Chengyu Jiang |
| 3 |
[GO] |
2023―Dez―08 |
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease |
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, Prasan Kumar Panda, Pravindra Kumar, Gaurav Kumar Sharma, Shailly Tomar |
| 4 |
[GO] |
2023―Mrz―27 |
Anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors in COVID-19 |
Habib Yaribeygi, Mina Maleki, Stephen L. Atkin, Prashant Kesharwani, Tannaz Jamialahmadi, Amirhossein Sahebkar |
| 5 |
[GO] |
2022―Nov―09 |
Involvement of sialoglycans in
SARS-COV
-2 infection: opportunities and challenges for glyco-based inhibitors |
Sakonwan Kuhaudomlarp, Anne Imberty |
| 6 |
[GO] |
2022―Apr―05 |
Herbal inhibitors of
SARS-CoV
-2 M
pro
effectively ameliorate acute lung injury in mice |
Xinyi Du, Longxin Xu, Yiming Ma, Shuaiyao Lu, Kegong Tang, Xiangyu Qiao, Jiaqi Liu, Xiaona Wang, Xiaozhong Peng, Chengyu Jiang |
| 7 |
[GO] |
2021―Nov―15 |
Underlying selection for the diversity of Spike protein sequences of
SARS-CoV
-2 |
Manisha Ghosh, Surajit Basak, Shanta Dutta |
| 8 |
[GO] |
2021―Aug―21 |
2-Deoxy-D
-glucose Exploits Increased Glucose Metabolism in Cancer and Viral- infected cells: Relevance to its use in
INDIA
Against
SARS-CoV
-2 |
Enrique A. Mesri, Theodore J. Lampidis |
| 9 |
[GO] |
2021―Aug―13 |
Endoplasmic reticulum
stress and
NF-kB
activation in
SARS-CoV
-2 infected cells and their response to antiviral therapy |
Desirée Bartolini, Anna Maria Stabile, Carmine Vacca, Alessandra Pistilli, Mario Rende, Antimo Gioiello, Gabriele Cruciani, Francesco Galli |
| 10 |
[GO] |
2021―Jun―12 |
The lethal internal face of the coronaviruses: Kidney tropism of the
SARS
,
MERS
, and
COVID
-19 viruses |
Roza Motavalli, Walid Kamal Abdelbasset, Heshu Sulaiman Rahman, Muhammad Harun Achmad, Angelina Olegovna Zekiy, Ali Adili, Farhad Motavalli Khiavi, Faroogh Marofi, Mehdi Yousefi, Shadi Ghoreishizadeh, Navid Shomali, Jalal Etemadi, Mostafa Jarahian |
| 11 |
[GO] |
2021―Mrz―22 |
Identification of mutation resistance coldspots for targeting the
SARS-CoV2
main protease |
Navaneethakrishnan Krishnamoorthy, Khalid Fakhro |
| 12 |
[GO] |
2020―Okt―08 |
Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2 |
Vignesh Mariappan, Rao S. R., Agieshkumar Balakrishna Pillai |
| 13 |
[GO] |
2020―Sep―16 |
SARS-CoV
-2 multifaceted interaction with the human host. Part
II
: Innate immunity response, immunopathology, and epigenetics |
Tasnim H. Beacon, Ruey-Chyi Su, Ted M. Lakowski, Geneviève P. Delcuve, James R. Davie |
| 14 |
[GO] |
2020―Sep―15 |
SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities |
Geneviève P. Delcuve, Ted M. Lakowski, Ruey-Chyi Su, Tasnim H. Beacon, James R. Davie |
| 15 |
[GO] |
2020―Aug―28 |
Vitamin
B12
may inhibit
RNA-dependent-RNA
polymerase activity of nsp12 from the
SARS-CoV
-2 virus |
Naveen Narayanan, Deepak T. Nair |
| 16 |
[GO] |
2020―Aug―08 |
Bacterial co-infections with SARS-CoV-2 |
Rasoul Mirzaei, Pedram Goodarzi, Muhammad Asadi, Ayda Soltani, Hussain ali abraham Aljanabi, Ali Salimi Jeda, Shirin Dashtbin, Saba Jalalifar, Rokhsareh Mohammadzadeh, Ali Teimoori, Kamran Tari, Mehdi Salari, Sima Ghiasvand, Sima Kazemi, Rasoul Yousefimashouf, Hossein Keyvani, Sajad Karampoor |
|
